Skip to main content

Table 1 Clinical characteristics of patients

From: Impact of postoperative patient-prosthesis mismatch as a risk factor for early structural valve deterioration after aortic valve replacement with Trifecta bioprosthesis

Valuable, mean ± SD, n (%)

Early SVD (n = 7)

No SVD (n = 103)

P value

Age, years

74.9 ± 7.8

78.3 ± 5.0

0.26

Age > 70

5 (71)

98 (95)

0.33

Male

2 (29)

49 (48)

0.33

BSA

1.51 ± 0.20

1.54 ± 0.18

0.61

Hypertension

6 (86)

73 (71)

0.4

Diabetes

1 (14)

28 (27)

0.45

Dyslipidemia

4 (57)

37 (36)

0.26

Ischemic heart disease

1 (14)

7 (7)

0.46

Dialysis

0 (0)

1 (1)

0.93

Left ventricular ejection fraction < 50%

1 (14)

10 (10)

0.53

Bicuspid aortic valve

1 (14)

8 (8)

0.8

Annulus size

20.1 ± 1.5

20.9 ± 2.5

0.47

Valsalva size

30.1 ± 2.0

32.5 ± 4.1

0.14

STJ size

25.3 ± 3.3

26.0 ± 4.0

0.63

CPB time, min

196 ± 80

168 ± 62

0.25

Cross-clamp time, min

139 ± 75

114 ± 46

0.18

Valve size

  

0.4

 19 mm

5 (71)

42 (41)

0.13

 21 mm

2 (29)

42 (41)

 

 23 mm

0 (0)

12 (12)

 

 25 mm

0 (0)

7 (7)

 

Supra-annular position

3 (43)

27 (26)

0.35

Concomitant procedures

   

 Coronary artery bypass grafting

1 (14)

21 (20)

0.69

 Mitral/tricuspid

3 (43)

29 (28)

0.41

 Others

2 (29)

34 (33)

0.93

  1. Data are expressed as mean ± SD or n (%)
  2. SD, Standard deviation; SVD, structural valve deterioration; BSA, body surface area; STJ, sino-tubular junction; CPB, cardiopulmonary bypass